免疫功能低下患者的进行性脑病伴新肺不张

Marika Orlov MD, PhD , Andrew T. Pham MD , Dan Merrick MD , Markus Wu MD , Sias Scherger MD , Tanya Marvi MD , Arun Kannappan MD
{"title":"免疫功能低下患者的进行性脑病伴新肺不张","authors":"Marika Orlov MD, PhD ,&nbsp;Andrew T. Pham MD ,&nbsp;Dan Merrick MD ,&nbsp;Markus Wu MD ,&nbsp;Sias Scherger MD ,&nbsp;Tanya Marvi MD ,&nbsp;Arun Kannappan MD","doi":"10.1016/j.chstcc.2024.100064","DOIUrl":null,"url":null,"abstract":"<div><h3>Case Presentation</h3><p>A 48-year-old man with history of recent travel to central Mexico and immunosuppression sought treatment with a 1-month-long history of progressive headache, fatigue, word-finding difficulties, and night sweats. The patient had a history of end-stage renal disease; he had undergone a kidney transplantation 7 years prior with good graft function with immunosuppression with tacrolimus, everolimus, and low-dose prednisone. At an outside hospital, he recently had been treated with empiric antibiotics for meningitis, but these were discontinued given the low suspicion for a bacterial cause. After discharge, he continued to have headaches, limited oral intake, persistent nausea, urinary frequency, and falls, prompting him to seek treatment at the ED. Physical examination findings were benign aside from disorientation. Laboratory workup was significant for hyponatremia of 122 mM, creatinine of 1.4 mg/dL (baseline, 1.4-1.5 mg/dL), WBC count of 7.2 10<sup>9</sup>/L, hemoglobin of 13 g/dL, and platelet count of 349 10<sup>9</sup>/L. Neither tacrolimus nor everolimus levels were supratherapeutic.</p></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"2 2","pages":"Article 100064"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949788424000182/pdfft?md5=617f09c10c4baecdf6ac902705093b61&pid=1-s2.0-S2949788424000182-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Progressive Encephalopathy With New Pulmonary Opacities in an Immunocompromised Host\",\"authors\":\"Marika Orlov MD, PhD ,&nbsp;Andrew T. Pham MD ,&nbsp;Dan Merrick MD ,&nbsp;Markus Wu MD ,&nbsp;Sias Scherger MD ,&nbsp;Tanya Marvi MD ,&nbsp;Arun Kannappan MD\",\"doi\":\"10.1016/j.chstcc.2024.100064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Case Presentation</h3><p>A 48-year-old man with history of recent travel to central Mexico and immunosuppression sought treatment with a 1-month-long history of progressive headache, fatigue, word-finding difficulties, and night sweats. The patient had a history of end-stage renal disease; he had undergone a kidney transplantation 7 years prior with good graft function with immunosuppression with tacrolimus, everolimus, and low-dose prednisone. At an outside hospital, he recently had been treated with empiric antibiotics for meningitis, but these were discontinued given the low suspicion for a bacterial cause. After discharge, he continued to have headaches, limited oral intake, persistent nausea, urinary frequency, and falls, prompting him to seek treatment at the ED. Physical examination findings were benign aside from disorientation. Laboratory workup was significant for hyponatremia of 122 mM, creatinine of 1.4 mg/dL (baseline, 1.4-1.5 mg/dL), WBC count of 7.2 10<sup>9</sup>/L, hemoglobin of 13 g/dL, and platelet count of 349 10<sup>9</sup>/L. Neither tacrolimus nor everolimus levels were supratherapeutic.</p></div>\",\"PeriodicalId\":93934,\"journal\":{\"name\":\"CHEST critical care\",\"volume\":\"2 2\",\"pages\":\"Article 100064\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949788424000182/pdfft?md5=617f09c10c4baecdf6ac902705093b61&pid=1-s2.0-S2949788424000182-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CHEST critical care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949788424000182\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

病例介绍 一位 48 岁的男性患者,近期曾前往墨西哥中部旅行,并有免疫抑制病史,因持续性头痛、乏力、寻词困难和盗汗已有 1 个月的病史而就诊。患者有终末期肾病史;7 年前接受过肾移植手术,移植功能良好,使用他克莫司、依维莫司和小剂量泼尼松进行免疫抑制。最近,他因脑膜炎在一家外院接受了经验性抗生素治疗,但由于对细菌性病因的怀疑较低,因此停用了抗生素。出院后,他仍有头痛、口服药物受限、持续恶心、尿频和跌倒等症状,因此到急诊室就诊。体格检查结果除迷失方向外均为良性。实验室检查结果为:低钠血症 122 毫摩尔,肌酐 1.4 毫克/分升(基线为 1.4-1.5 毫克/分升),白细胞计数 7.2 109/升,血红蛋白 13 克/分升,血小板计数 349 109/升。他克莫司和依维莫司的水平均未超过治疗水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Progressive Encephalopathy With New Pulmonary Opacities in an Immunocompromised Host

Case Presentation

A 48-year-old man with history of recent travel to central Mexico and immunosuppression sought treatment with a 1-month-long history of progressive headache, fatigue, word-finding difficulties, and night sweats. The patient had a history of end-stage renal disease; he had undergone a kidney transplantation 7 years prior with good graft function with immunosuppression with tacrolimus, everolimus, and low-dose prednisone. At an outside hospital, he recently had been treated with empiric antibiotics for meningitis, but these were discontinued given the low suspicion for a bacterial cause. After discharge, he continued to have headaches, limited oral intake, persistent nausea, urinary frequency, and falls, prompting him to seek treatment at the ED. Physical examination findings were benign aside from disorientation. Laboratory workup was significant for hyponatremia of 122 mM, creatinine of 1.4 mg/dL (baseline, 1.4-1.5 mg/dL), WBC count of 7.2 109/L, hemoglobin of 13 g/dL, and platelet count of 349 109/L. Neither tacrolimus nor everolimus levels were supratherapeutic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CHEST critical care
CHEST critical care Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信